Trial
NCT01078974
Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Steven P. Treon, MD, PhD
Collaborators
Celgene Corporation
Condition
Waldenstrom's Macroglobulinemia
Intervention
pomalidomide
Why stopped
Safety concerns (IgM Flare)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-25